Abstract
Purpose
Thyroid dysfunction has been reported in hypercortisolism. Previous findings regarding changes in thyroid function due to cortisol-producing adenoma (CPA) have been inconsistent. The study aimed to investigate the association between thyroid function and excessive cortisol secretion in patients with CPA and to explore the changes in pituitary function after adrenalectomy.
Methods
We conducted a retrospective study; thyroid function was evaluated in 94 patients with CPA and 94 healthy controls (HC) matched for age and sex. A total of 94 patients with nonfunctioning adrenal incidentalomas (NFAIs) were recruited as a second control group.
Results
Serum thyroid stimulating hormone (TSH) and free thyroxine (T4) levels were significantly lower in the CPA group than in the HC and NFAIs groups (P < 0.001). The prevalence of central hypothyroidism was 12.8% in the CPA group and increased according to serum cortisol quartiles (P for trend = 0.025). According to the stepwise multiple linear regression analysis, serum cortisol was negatively associated with TSH and free T4 levels in the CPA group after adjustment for body mass index and age. Furthermore, decreased TSH levels were corrected by adrenalectomy [0.75 (0.50, 1.14) vs. 1.91 (1.36, 2.71) µIU/ml, P < 0.001], in parallel with a recovery in free T4 levels [11.20 (10.00, 12.43) vs. 12.04 (11.24, 13.01), P < 0.001]. Postoperative growth hormone and prolactin levels did not change compared with baseline.
Conclusion
Serum TSH and free T4 levels were decreased in patients with CPA, and dysfunction of the hypothalamic–pituitary–thyroid axis might be reversible after surgery.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386(9996), 913–927 (2015). https://doi.org/10.1016/S0140-6736(14)61375-1
N. Mathioudakis, S. Thapa, G.S. Wand, R. Salvatori, ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types. Clin. Endocrinol. 77(6), 871–876 (2012). https://doi.org/10.1111/j.1365-2265.2012.04442.x
S.C. Dogansen, G.Y. Yalin, B. Canbaz, S. Tanrikulu, S. Yarman, Dynamic changes of central thyroid functions in the management of Cushing’s syndrome. Arch. Endocrinol. Metab. 62(2), 164–171 (2018). https://doi.org/10.20945/2359-3997000000019
J.T. Nicoloff, D.A. Fisher, M.D. Appleman, The role of glucocorticoids in the regulation of thyroid function in man. J. Clin. Investig. 49(10), 1922–1929 (1970). https://doi.org/10.1172/JCI106411
G. Brabant, A. Brabant, U. Ranft, K. Ocran, J. Köhrle, R.D. Hesch, A. von zur Mühlen, Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J. Clin. Endocrinol. Metab. 65(1), 83–88 (1987). https://doi.org/10.1210/jcem-65-1-83
A. Brabant, G. Brabant, T. Schuermeyer, U. Ranft, F.W. Schmidt, R.D. Hesch, A. von zur Mühlen, The role of glucocorticoids in the regulation of thyrotropin. Acta Endocrinol. 121(1), 95–100 (1989). https://doi.org/10.1530/acta.0.1210095
F. Roelfsema, A.M. Pereira, N.R. Biermasz, M. Frolich, D.M. Keenan, J.D. Vedhuis, J.A. Romijn, Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing’s syndrome. Eur. J. Endocrinol. 161(5), 695–703 (2009). https://doi.org/10.1530/EJE-09-0580
B. Xiang, R. Tao, X. Liu, X. Zhu, M. He, Z. Ma, Y. Yang, Z. Zhang, Y. Li, Z. Yao et al. A study of thyroid functions in patients with Cushing’s syndrome: a single-center experience. Endocr. Connect. 8(8), 1176–1185 (2019). https://doi.org/10.1530/EC-19-0309
L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). https://doi.org/10.1210/jc.2008-0125
M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175(2), G1–G34 (2016). https://doi.org/10.1530/EJE-16-0467
P. Beck-Peccoz, A. Lania, A. Beckers A, K. Chatterjee, J.L. Wemeau, European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur. Thyroid J. 2(2), 76–82 (2013). https://doi.org/10.1159/000351007
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, T.S.H. Serum, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87(2), 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182
V.M. da Costa, D.G. Moreira, D. Rosenthal, Thyroid function and aging gender-related differences. J. Endocrinol. 171(1), 193–198 (2001). https://doi.org/10.1677/joe.0.1710193
G. Benker, M. Raida, T. Olbricht, R. Wagner, W. Reinhardt, D. Reinwein, TSH secretion in Cushing’s syndrome: relation to glucocorticoid excess, diabetes, goitre, and the ‘sick euthyroid syndrome’. Clin. Endocrinol. 33(6), 777–786 (1990). https://doi.org/10.1111/j.1365-2265.1990.tb03915.x
T.J. Visser, S.W. Lamberts, Regulation of TSH secretion and thyroid function in Cushing’s disease. Acta Endocrinol. 96(4), 480–483 (1981). https://doi.org/10.1530/acta.0.0960480
L. Bartalena, E. Martino, L. Petrini, F. Velluzzi, A. Loviselli, L. Grasso, C. Mammoli, A. Pinchera, The nocturnal serum thyrotropin surge is abolished in patients with adrenocorticotropin (ACTH)-dependent or ACTH independent Cushing’s syndrome. J. Clin. Endocrinol. Metab. 72(6), 1195–1199 (1991). https://doi.org/10.1210/jcem-72-6-1195
D. Tamada, T. Kitamura, T. Onodera, T. Hamasaki, M. Otsuki, I. Shimomura, Clinical significance of fluctuations in thyroid hormones after surgery for Cushing’s syndrome. Endocr. J. 62(9), 805–810 (2015). https://doi.org/10.1507/endocrj.EJ15-0001
C.A. Stratakis, G. Mastorakos, M.A. Magiakou, E. Papavasiliou, E.H. Oldfield, G.P. Chrousos, Thyroid function in children with Cushing’s disease before and after transsphenoidal surgery. J. Pediatr. 131(6), 905–909 (1997). https://doi.org/10.1016/S0022-3476(97)70041-6
C. Fekete, R.M. Lechan, Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. Endocr. Rev. 35(2), 159–194 (2014). https://doi.org/10.1210/er.2013-1087
A. Cintra, K. Fuxe, A.C. Wikström, T. Visser, J.A. Gustafsson, Evidence for thyrotropin-releasing hormone and glucocorticoid receptor immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat. Brain Res. 506(1), 139–144 (1990). https://doi.org/10.1016/0006-8993(90)91210-8
T. Mitsuma, T. Nogimori, Effects of dexamethasone on the hypothalamic-pituitary-thyroid axis in rats. Acta Endocrinol. 100(1), 51–56 (1982). https://doi.org/10.1530/acta.0.1000051
M. Szabo, L.A. Frohman, Suppression of cold-stimulated thyrotropin secretion by antiserum to thyrotropin-releasing hormone. Endocrinology 101(4), 1023–1033 (1997). https://doi.org/10.1210/endo-101-4-1023
A. Alkemade, U.A. Unmehopa, W.M. Wiersinga, D.F. Swaab, E. Fliers, Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. J. Clin. Endocrinol. Metab. 90(1), 323–327 (2005). https://doi.org/10.1210/jc.2004-1430
L.M. Saane, E. Carro, S. Tovar, F.F. Casanueva, C. Dieguez, Regulation of in vivo TSH secretion by leptin. Regul. Pept. 92(1–3), 25–29 (2000). https://doi.org/10.1016/S0167-0115(00)00145-2
B.M. Lewis, C. Dieguez, M.D. Lewis, M.F. Scanlon, Dopamine stimulates release of thyrotropin-releasing hormone from perfused intact rat hypothalamus via hypothalamic D2-receptors. J. Endocrinol. 115(3), 419–424 (1987). https://doi.org/10.1677/joe.0.1150419
A.D. Taylor, J.G. Philip, C.D. John, P.O. Cover, J.F. Morris, R.J. Flower, J.C. Buckingham, Annexin 1 (lipocortin 1) mediates the glucocorticoid inhibition of cyclic adenosine 3’,5’-monophosphate-stimulated prolactin secretion. Endocrinology 141(6), 2209–2219 (2000). https://doi.org/10.1210/endo.141.6.7512
C. Estupina, J. Belmar, L. Tapia-Arancibia, H. Astier, S. Arancibia, Rapid and opposite effects of dexamethasone on in vivo and in vitro hypothalamic somatostatin release. Exp. Brain Res. 113(2), 337–342 (1997). https://doi.org/10.1007/bf02450331
B.R. Haugen, Drugs that suppress TSH or cause central hypothyroidism. Best. Pract. Res Clin. Endocrinol. Metab. 23(6), 793–800 (2009). https://doi.org/10.1016/j.beem.2009.08.003
Acknowledgements
We thank Yu Zhu, MD. Ph.D, Department of Urology; Fukang Sun, MD. Ph.D, Department of Urology; Zhiyuan Wu, MD. Ph.D, Department of Radiology; and Jing Xie, MD, Department of Pathology for their help.
Funding
This work was supported by National Natural Science Foundation of China (Nos. 91857205, 81730023, and 81400779), Shanghai Municipal Commission of Health and Family Planning (201840049 and 201740040), the National Key Research and Development Program of China (2018YFC1311800), National International Science Cooperation Foundation (2015DFA30560), Chinese Society of Endocrinology (13050890474), Shanghai Science and Technology Committee (15411966600), Shanghai Medical and health development foundation (805344), and Shanghai Ruijin Hospital (20193701).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by the Ethics Committee of the Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine.
Informed consent
Written informed consents were obtained from all of the participants.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cai, R., Zhou, W., Jiang, L. et al. Association between thyroid function and serum cortisol in cortisol-producing adenoma patients. Endocrine 69, 196–203 (2020). https://doi.org/10.1007/s12020-020-02278-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02278-5